Heidi Savage

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index2.3kcitations132works2.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(56), Chronic Lymphocytic Leukemia Research(26), Advanced Breast Cancer Therapies(21), Lung Cancer Treatments and Mutations(20), Synthesis and biological activity(15)

Publications132 total

Rethinking the Design of Bikes and Bike Networks for Seniors: Sustainability, Climate Change, Alzheimer’s Disease, and Caregivers
Sustainability·2024· 2 citedOpen Access
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Genome Medicine·2023· 19 citedOpen Access
Supplementary Figure S1 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Supplementary Figure S3 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Figures S1,2,4-8 from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
2023Open Access
Supplemental Methods from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
2023Open Access
Supplementary Tables 1 through 4 and Supplementary Figures 1 through 7 from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Figures S1,2,4-8 from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
2023Open Access
Supplementary Figure S7 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Figure S3 from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
2023Open Access
Supplementary Figure S2 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Supplementary Figure S3 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Supplementary Figure S6 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Data from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Supplementary Figure S5 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Data from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
Table S1 from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
2023Open Access
Data from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Supplementary Tables 1 through 4 and Supplementary Figures 1 through 7 from Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2023Open Access
Supplementary Figure S7 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Mark R. Lackner(29), Timothy R. Wilson(27), Carol O’Brien(22), Jill M. Spoerke(15), Lukas C. Amler(12), Elizabeth A. Punnoose(9), Lori S. Friedman(8), Ian E. Krop(7), Deepak Sampath(7), Jeffrey J. Wallin(7), Ethan S. Sokol(7), Heather M. Moore(7), Marcia Belvin(6), Lori S. Friedman(6), Junko Aimi(6), Joyce O’Shaughnessy(6), Michael E. Goldberg(6), Ciara Metcalfe(6), Zachary Boyd(5), Dejan Juric(5)